Sustainability & Climate

Taiwan's SynbioTech is launching a science-backed probiotic portfolio at Vitafoods Europe, targeting a holistic approach to women's active aging.

With CHF 2.5 million in new seed funding, Swiss-based Oberland Biotech is set to tackle the competitive US and Asian nutritional food markets.

A new gene therapy has helped completely blind patients with Retinitis Pigmentosa regain light perception, offering hope to millions with inherited blindness.

Aalberts N.V. returns to organic growth in Q1 2026, driven by its 'thrive 2030' strategy, successful acquisitions, and operational improvements.

A landmark Carnegie Hall concert saw young U.S. and Chinese musicians use AI to compose new works, blending tradition with tech to foster global unity.

Medtech firm TELA Bio overhauls its board with M&A and turnaround experts, signaling a major strategic shift to accelerate growth and escape losses.

The consulting firm posted double-digit Q1 growth, fueled by its critical role in securing AI-powered products and fortifying energy infrastructure.

With cash burn rising, Summit Therapeutics races toward a November FDA decision on its novel cancer drug ivonescimab and a major data reveal at ASCO.

A new program offers local manufacturers integrated financial, strategic, and PR support at a fraction of the cost, aiming to boost a key regional industry.

A massive data expansion is giving investors unprecedented visibility into smaller senior housing markets just as demographic demand surges to historic highs.

In a move toward greater transparency, Carequality invites external experts to help steer the future of national health data exchange and interoperability.

Despite a 19% revenue jump amidst Greece's record tourism year, hotel group The Azur Selection posts a €5.7M loss, triggering a 'going concern' warning.

A new partnership aims to make powerful FPGA chips accessible to hobbyists and startups, potentially sparking a new wave of hardware innovation.

A new partnership between Collectly and Sunbit uses AI and instant financing to make healthcare affordable, promising cost transparency for patients and providers.

Eli Lilly begins a crucial Phase 2 study for a novel, non-addictive pain drug from Confo Therapeutics, a major step in the hunt for an opioid alternative.

A new book argues modern genomics is stuck on a 'parts list.' Can an architectural approach called 'Deterministic Convergence' build a better future for health?

A new Northwestern study shows California's Soluna app significantly reduces youth distress, anxiety, and depression, with benefits sustained over months.

As Davidson Homes expands into Charlotte's suburbs, the national builder promises value. What does its entry mean for local competition and homebuyers?

A massive $65 billion technology park is rising in rural Indiana, promising thousands of jobs and a new, community-focused model for megaprojects.

For the first time, Canada's biggest cities are shrinking. New data reveals where people are going and what it means for every business and community.